Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:16-24

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, Y.
Right arrow Articles by Kajiyama, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, Y.
Right arrow Articles by Kajiyama, G.

(Hypertension. 1998;32:16-24.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Angiotensin-Converting Enzyme Inhibition, But Not Calcium Antagonism, Improves a Response of the Renal Vasculature to L-Arginine in Patients With Essential Hypertension

Yukihito Higashi; Tetsuya Oshima; Shota Sasaki; Yukiko Nakano; Masayuki Kambe; Hideo Matsuura; ; Goro Kajiyama

From the First Department of Internal Medicine (Y.H., S.S., H.M., G.K.) and the Department of Clinical Laboratory Medicine (T.O., Y.N., M.K.), Hiroshima University School of Medicine, Japan.

Correspondence to Yukihito Higashi, MD, PhD, First Department of Internal Medicine, Hiroshima University School of Medicine, 1–2-3 Kasumi, Minami-ku, Hiroshima 734, Japan. E-mail yhigashi{at}mcai.med.hiroshima-u.ac.jp

Abstract—Endothelial function has been shown to be impaired in patients with essential hypertension. The purpose of the present study was to determine whether antihypertensive drug therapy improves impaired endothelium-dependent renal vasorelaxation in essential hypertensive patients without atherosclerosis. We evaluated the effects of intravenous infusion of L-arginine (500 mg/kg given over 30 minutes) on systemic and renal hemodynamics in 27 patients with mild to moderate essential hypertension who were randomly assigned to treatment with either the angiotensin-converting enzyme inhibitor imidapril or the calcium antagonist amlodipine for 12 weeks in a double-blind fashion. After the 12 weeks, the decrease in blood pressure was similar in the imidapril (n=14) and amlodipine (n=13) groups. The increase in renal plasma flow was also similar in both groups. L-Arginine–induced renovascular relaxation was increased by imidapril (renal plasma flow, 9.6±5.1% to 14.4±7.4%; renal vascular resistance, -10.4±8.1% to -16.7±9.2%, P<0.05, respectively) but not by amlodipine. Urinary excretion of nitrite/nitrate in response to L-arginine was significantly increased by imidapril (90±29% to 134±63%, P<0.05) but remained unchanged by amlodipine. These findings suggest that angiotensin-converting enzyme inhibition improves the impaired endothelium-dependent renovascular relaxation in patients with essential hypertension due to the increase in nitric oxide production and that the reduction in blood pressure with a calcium antagonist does not play a major role in the potentiation of L-arginine/nitric oxide–mediated effects.


Key Words: angiotensin-converting enzyme inhibitor • calcium antagonist • nitric oxide • endothelium • kidney • hypertension, essential




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Xenakis, C Tentolouris, G Davies, C Antoniades, T Crake, and C Stefanadis
Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina
Heart, October 1, 2005; 91(10): 1319 - 1323.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Sasaki, H. M. Siragy, J. J. Gildea, R. A. Felder, and R. M. Carey
Production and Role of Extracellular Guanosine Cyclic 3', 5' Monophosphate in Sodium Uptake in Human Proximal Tubule Cells
Hypertension, February 1, 2004; 43(2): 286 - 291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kirima, K. Tsuchiya, H. Sei, T. Hasegawa, M. Shikishima, Y. Motobayashi, K. Morita, M. Yoshizumi, and T. Tamaki
Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H589 - H596.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Delles, M. P. Schneider, S. Oehmer, E. H. Fleischmann, and R. E. Schmieder
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Not Altered in Hypertensive Patients With Type 2 Diabetes
Diabetes Care, June 1, 2003; 26(6): 1836 - 1840.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. N. Friedman, C. Ritter, J. C. F. Moreira, F. Dal-Pizzol, M. G. Ziegler, X. Bao, R. Matz, Y. Higashi, K. Chayama, and M. Yoshizumi
Renovascular Hypertension, Endothelial Function, and Oxidative Stress
N. Engl. J. Med., November 7, 2002; 347(19): 1528 - 1530.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Wassmann, S. Hilgers, U. Laufs, M. Bohm, and G. Nickenig
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction
Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1208 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
T. Elung-Jensen, J. Heisterberg, A.-L. Kamper, J. Sonne, S. Strandgaard, and N. E. Larsen
High serum enalaprilat in chronic renal failure
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 240 - 245.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. A. EARLE, S. MEHROTRA, R. N. DALTON, E. DENVER, and R. SWAMINATHAN
Defective Nitric Oxide Production and Functional Renal Reserve in Patients with Type 2 Diabetes Who Have Microalbuminuria of African and Asian Compared with White Origin
J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2125 - 2130.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, G. Kajiyama, and T. Oshima
Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Higashi, S. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima
A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Higashi, S. Sasaki, S. Kurisu, A. Yoshimizu, N. Sasaki, H. Matsuura, G. Kajiyama, and T. Oshima
Regular Aerobic Exercise Augments Endothelium-Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects : Role of Endothelium-Derived Nitric Oxide
Circulation, September 14, 1999; 100(11): 1194 - 1202.
[Abstract] [Full Text] [PDF]